The North America Fabry Disease Treatment Market is witnessing steady growth as advancements in rare disease research, improved diagnostic capabilities, and expanding treatment options continue to transform patient care. According to Polaris Market Research, the market was valued at USD 1,197.90 Million in 2025 and is projected to reach USD 2,173.14 Million by 2034, registering a CAGR of 6.80%...